Cargando…
Targeting the Endocannabinoidome in Pancreatic Cancer
Pancreatic Ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, is an aggressive and lethal form of cancer with a very high mortality rate. High heterogeneity, asymptomatic initial stages and a lack of specific diagnostic markers result in an end-stage diagnosis when the tumour...
Autores principales: | Falasca, Valerio, Falasca, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869154/ https://www.ncbi.nlm.nih.gov/pubmed/35204820 http://dx.doi.org/10.3390/biom12020320 |
Ejemplares similares
-
Diet and Pancreatic Cancer Prevention
por: Casari, Ilaria, et al.
Publicado: (2015) -
Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
por: Ishiguro, Hiroki
Publicado: (2023) -
Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
por: Di Marzo, Vincenzo, et al.
Publicado: (2019) -
ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
por: Adamska, Aleksandra, et al.
Publicado: (2018) -
Targeting PDK1 for Chemosensitization of Cancer Cells
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2017)